Compared with the usual calm of public policy debates, the Cass Review represents a political and medical firestorm.

Its findings led UK health services to ban puberty blockers for routine use in those under 18 with gender dysphoria — a ban which in my view should also be adopted in Australia, to protect vulnerable children from harm.